WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003004501) (HETERO) ARYL SUBSTITUTED BENZOFURANS AS 5-HT LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/004501    International Application No.:    PCT/US2002/020155
Publication Date: 16.01.2003 International Filing Date: 24.06.2002
Chapter 2 Demand Filed:    17.01.2003    
IPC:
C07D 491/04 (2006.01)
Applicants: PHARMACIA & UPJOHN COMPANY [US/US]; 301 Henrietta Street, Kalamazoo, MI 49001 (US) (For All Designated States Except US).
MCWHORTER, William, W., Jr. [US/US]; (US) (For US Only).
BADESCU, Valentina [US/US]; (US) (For US Only)
Inventors: MCWHORTER, William, W., Jr.; (US).
BADESCU, Valentina; (US)
Agent: THIEL, Dale, H.; Flynn, Thiel, Boutell & Tanis, P.C., 2026 Rambling Road, Kalamazoo, MI 49008-1631 (US)
Priority Data:
60/303,191 05.07.2001 US
60/314,972 24.08.2001 US
Title (EN) (HETERO) ARYL SUBSTITUTED BENZOFURANS AS 5-HT LIGANDS
(FR) COMPOSES THERAPEUTIQUES
Abstract: front page image
(EN)The present invention provides coupounds of formula (I): wherein R1, R2, R3, R4, R5, R6, X, ---, m, and n have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts thereof. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of formula (I). The compounds are useful as 5-HT ligands.
(FR)L'invention concerne des composés représentés par la formule (I), dans laquelle R1, R2, R3, R4, R5, R6, X, ---, m, et n ont n'importe quelle valeur définie par le descriptif, ainsi que des compositions pharmaceutiques contenant lesdits composés ou des sels de ceux-ci. Par ailleurs, l'invention concerne des méthodes thérapeutiques, des procédés et des intermédiaires utilisés pour préparer les composés de formule (I). Ces composés sont utilisés comme ligands 5-HT.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)